Series E - CG Oncology - 2022-11-15 - Crunchbase
Nov 15, 2022 · CG Oncology raised $120000000 on 2022-11-15 in Series E. ORI Capital ORI Fund is a venture capital fund that invests in innovative companies with disruptive …
OFF
Series E - CG Oncology - 2022-11-15 - Crunchbase
4 weeks from now
Nov 15, 2022 · CG Oncology raised $120000000 on 2022-11-15 in Series E. ORI Capital ORI Fund is a venture capital fund that invests in innovative companies with disruptive …
crunchbase.com
OFF
CG Oncology Raises $120 Million In Oversubscribed Series E …
4 weeks from now
Our lead candidate, CG0070, is an intravesically delivered oncolytic immunotherapy agent in a Phase 3 trial for the treatment of BCG-unresponsive non-muscle invasive bladder cancer. CG0070 is also in a Phase 2 study in combination with KEYTRUDA® (pembrolizumab) in the same indication. Other types of bladder cancer are being evaluated with CG0070 in...
cgoncology.com
OFF
CG Oncology Raises $120 Million In Oversubscribed Series E …
4 weeks from now
IRVINE, Calif., November 15, 2022--CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline
yahoo.com
OFF
CG Oncology Completes $120M Series E - Vcnewsdaily.com
4 weeks from now
Nov 15, 2022 · CG Oncology, an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers, today announced the close of an …
vcnewsdaily.com
OFF
Malin : CG Oncology Raises $120 Million In Oversubscribed Series …
4 weeks from now
Nov 15, 2022 · - Brian Liu, M.D., Principal, Longitude Capital to join board of directors - IRVINE, Calif., November 15, 2022 - CG Oncology, Inc., an oncolytic immunotherapy company focused …
marketscreener.com
OFF
CG Oncology Raises $120M For Research - Orange County …
4 weeks from now
Nov 21, 2022 · The immunotherapy company on Nov. 15 announced it raised $120 million in a Series E financing round that was oversubscribed. ... CG Oncology, which has ongoing Phase …
pressreader.com
OFF
Latham & Watkins Advises CG Oncology In US$120 Million Series …
4 weeks from now
Nov 30, 2022 · CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers, has announced the close of an …
lw.com
OFF
CG Oncology Raises $120 Million In Oversubscribed Series E
4 weeks from now
Nov 15, 2022 · CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers, today announced the close of an …
biospace.com
OFF
CG Oncology Raises $120m Through Series E Round
4 weeks from now
CG Oncology, an oncolytic immunotherapy company, has raised $120m through Series E financing round to advance its lead clinical programmes in bladder cancer towards FDA …
pharmaceutical-business-review.com
OFF
The 10 Biggest Rounds Of November: Aspen Powers Up With …
4 weeks from now
Dec 8, 2022 · The enterprise data intelligence startup raised a $123 million Series E led by Thoma Bravo, ... CG Oncology, $120M, ... diseases. The startup plans to target cells such as plasma …
crunchbase.com
OFF
CG Oncology Picks Up $120M - PitchBook
4 weeks from now
Nov 17, 2022 · Biotech startup CG Oncology, which is developing immunotherapies for urologic cancers, has raised a $120 million Series E co-led by ORI Capital, Longitude Capital and …
pitchbook.com
OFF
CG Oncology Raises $120 Million In Oversubscribed Series E …
4 weeks from now
On November 15, 2022 CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers, reported the close of an …
1stoncology.com
OFF
Series A - Haystack Oncology - 2022-11-16 - Crunchbase
4 weeks from now
Nov 16, 2022 · Haystack Oncology raised $56000000 on 2022-11-16 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension ... haystackoncology.com — Haystack …
crunchbase.com
OFF
CG Oncology Raises $120 Million In Oversubscribed Series E …
4 weeks from now
IRVINE, Calif., November 15, 2022-- CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers, today announced …
vcaonline.com
OFF
Series C - Casma Therapeutics - 2022-11-15 - Crunchbase
4 weeks from now
Nov 15, 2022 · Casma Therapeutics raised $46000000 on 2022-11-15 in Series C. Search Crunchbase. Start Free Trial ... Save . Summary. Overview. Edit Overview Section. …
crunchbase.com
FAQs about Series E - CG Oncology - 2022-11-15 - Crunchbase Coupon?
Who owns CG oncology?
How many investors does CG oncology have?
Who is CG oncology?
When did CG oncology close?
Did CG oncology raise money?
Where is CG oncology located?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
